Delivery Order SPE2DB20D1100-SPE2DB24FB4K3
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Remifentanil 1 mg vials. The contract has a ceiling value of $1,755.60 and a period of performance through October 31, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 1 mg vials of the pharmaceutical drug remifentanil, with a firm fixed price ceiling value of $3,072.30 and a completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,816.30 delivery order is for the supply of REMIFENTANIL 2 MG VIALS, a specialty medication, to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of March 25, 2025. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, with a ceiling value of $11,351.75 and a performance period extending through June 13, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, a prescription medication. The contract has a firm fixed price, a ceiling value of $9,989.54, and an ultimate completion date of June 26, 2025. This delivery order is not set aside for any specific business type. Amerisourcebergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2 mg vials of the medication Remifentanil, with a ceiling value of $1,676.23 and a period of performance through July 1, 2025. The contract is a firm fixed-price, non-set-aside award, meaning it was open to full and open competition. AmerisourceBergen Drug Corporation...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of remifentanil 1 mg vials, a specialty medication used for pain management. The contract has a ceiling value of $8,173.26 and runs through February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,100.19 firm-fixed-price contract is for the delivery of Remifentanil 1 mg vials, a specialty medication used for pain management. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,022.40 firm-fixed-price contract is for the supply of 2 mg vials of the drug remifentanil, a potent opioid analgesic. The award has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,637.53 firm fixed-price contract is for the delivery of remifentanil 2 mg vials, a specialty medication used for pain management. The delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB4K3Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,266.80. The contract is for the supply of REMIFENTANIL 1 MG VIALS, a pharmaceutical product used for anesthesia and pain management. The award has a firm-fixed price and is not associated with any set-aside designations. AmerisourceBergen Drug Corp, through its Corporate Office Division, has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is likely part of that larger IDC, which enables DLA to efficiently procure essential medical commodities for military treatment programs and facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 4/24/24 |